This is a working overview of freeze-dried powder, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-26. Anything still debated is marked as such rather than presented as settled.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
| Property | Value | Notes |
|---|---|---|
| Origin | Fragment of a protein found in human gastric juice | Sequence corresponds to a fifteen-residue portion of the parent protein |
| Sequence | GEPPPGKPADDAGLV | Single linear chain, fifteen amino acids |
| Reported molecular weight | About 1419 daltons | Value quoted consistently in supplier and review literature |
| Regulatory status | Not an approved human medicine in the US or EU | Handled and sold as a research chemical |
| Sports status | Listed as prohibited | Falls under non-approved-substance categories in anti-doping codes |
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
The idea that all living things (including things considered non-living by science) are related is a recurring theme in many indigenous worldviews across the world. Later on, in the 1740s, the French mathematician Pierre Louis Maupertuis arrived at the idea that all organisms had a common ancestor, and had diverged through random variation and natural selection. In 1790, the philosopher Immanuel Kant wrote in Kritik der Urteilskraft (Critique of Judgment) that the similarity of animal forms implies a common original type, and thus a common parent. In 1794, Charles Darwin's grandfather, Erasmus Darwin asked:
As a result of the COVID-19 pandemic, biosecurity measures have become a highly visible aspect of border control across the globe. Most notably, quarantine and mandatory COVID-19 vaccination for international travelers. Together with a decreased willingness to travel, the implementation of biosecurity measures has had a negative economic and social impact on the travel industry. Slow travel gained popularity during the pandemic, with tourists visiting fewer destinations on their trips. Biosecurity measures such as restrictions on cross-border travel, the introduction of mandatory vaccination for international travellers, and the adoption of quarantine or mandatory testing measures have helped to contain the spread of COVID-19. While test-based border screening measures may prove effective under certain circumstances, they may fail to detect a significant quantity of positive cases if only conducted upon arrival without follow-up. A minimum 10-day quarantine may help prevent the spread of COVID-19 and may be more effective when combined with additional control measures, such as border screening. A study in Science found that travel restrictions could delay the initial arrival of COVID-19 in a country, but that they produced only modest overall effects unless combined with domestic infection prevention and control measures to reduce transmissions considerably. (That is consistent with prior research on influenza and other communicable diseases.) Travel bans early in the pandemic were most effective for isolated locations, such as small island nations.
nucleoplasm Also karyoplasm. All of the material enclosed within the nucleus of a cell by the nuclear envelope, analogous to the cytoplasm enclosed by the main cell membrane. Like the cytoplasm, the nucleoplasm is composed of a gel-like substance (the nucleosol) in which various organelles, nuclear proteins, and other biomolecules are suspended, including nuclear DNA in the form of chromosomes, the nucleolus, nuclear bodies, and free nucleotides.
Sources: en.wikipedia.org
== Inclusion of disorders == Newborn screening programs initially used screening criteria based largely on criteria established by JMG Wilson and F. Jungner in 1968. Although not specifically about newborn population screening programs, their publication, Principles and practice of screening for disease proposed ten criteria that screening programs should meet before being used as a public health measure. Newborn screening programs are administered in each jurisdiction, with additions and removals from the panel typically reviewed by a panel of experts. The four criteria from the publication that were relied upon when making decisions for early newborn screening programs were:
Ann Kihengu (2010 Africa Laureate) - Tanzanian energy distribution entrepreneur and founder of Pamoja Life, recognized for expanding solar energy and clean cookstove access in rural East Africa. Lianna Gunawan (2012 Asia-Pacific Laureate) - Indonesian footwear supply-chain executive and founder of Amanda Niaria, noted for introducing ethical manufacturing and community-based artisan sourcing to commercial footwear. Chinwe Ohajuruka (2015 Africa Laureate) - Nigerian green architect and founder of Comprehensive Design Services, specialized in producing affordable, solar-powered, and water-self-sufficient housing models for displaced populations. Temie Giwa-Tubosun (2020 Sub-Saharan Africa Fellow) - Nigerian health logistics pioneer and founder of LifeBank, a medical distribution company using tech and cold-chain infrastructure to deliver blood, oxygen, and vaccines to hospitals across Africa. Basima Abdulrahman (2021 Middle East & North Africa Laureate) - Iraqi structural engineer and founder of Kesk, recognized for establishing Iraq's first green building and sustainable engineering consultancy to build solar-powered infrastructure.
An active celebrity in the climate change movement, DiCaprio believes global warming is the world's "number-one environmental challenge". Eager to learn about ecology from an early age, he would watch documentaries on rainforest depletion and the loss of species and habitats. In 1998, he established the Leonardo DiCaprio Foundation, a non-profit organization devoted to promoting environmental awareness. It supports organizations and campaigns committed to ensuring a viable future for planet Earth, and produced the short web documentaries Water Planet and Global Warning. The foundation has also funded debt-for-nature swaps. By 2018, the foundation had funded more than 200 projects, providing $100 million in support. He has been an active supporter of numerous environmental organizations and sat on the board of the World Wildlife Fund and International Fund for Animal Welfare. DiCaprio has owned environment-friendly electric-hybrid vehicles. His use of private jets and large yachts have been criticized as hypocritical due to their large carbon footprints. DiCaprio chaired the national Earth Day celebration in 2000 where he interviewed Bill Clinton and they discussed plans to deal with global warming and the environment. He presented at the 2007 American leg of Live Earth. DiCaprio donated $1 million to the Wildlife Conservation Society at Russia's Tiger Summit. DiCaprio's persistence in reaching the event after encountering two plane delays caused then Prime Minister Vladimir Putin to describe him as a "muzhik" or "real man".
Sources: en.wikipedia.org
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.
The peptide was named after a protein fraction found in human gastric juice, and the shorter form was called body protection compound. That phrase was shortened to the abbreviation BPC. The number 157 refers to a laboratory designation used in the original isolation work.
Its sequence corresponds to a segment of a protein present in gastric secretions, but the material supplied for research is made synthetically. No commercial product is purified from human or animal tissue. The synthetic route is used because it gives a defined chain length and a reproducible sequence.
The letters BPC stand for body protection compound. The number 157 refers to a specific fragment designation from early work on gastric proteins. The full name is a label for a synthetic fifteen-amino-acid peptide rather than a naturally isolated drug.